SCHEMBL28758464

SCHEMBL28758464

CC(C)(C)[Si](NS(=O)(=O)c1cccc(N)c1)(c1ccccc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.52
▸ PRMT1 Q99873 1/20 0.47
▸ HTR6 P50406 1/20 0.46
▸ CA2 P00918 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ F2 P00734 3/20 0.43
▸ PRSS1 P07477 3/20 0.43
▸ PRSS2 P07478 3/20 0.43
▸ PRSS3 P35030 3/20 0.43
▸ CYP19A1 P11511 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA4 P22748 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ CA14 Q9ULX7 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ TSHR P16473 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28758462 0.79 CA2 (0.53) CA2LMNAF2PRSS1PRSS2
SCHEMBL23319836 0.76 RAPGEF3 (0.40) CYP19A1PKMALDH1A1
SCHEMBL29909995 0.76 RAPGEF3 (0.40) CYP19A1PKMALDH1A1
SCHEMBL29973441 0.72 LMNA (0.69) POLBPRMT1HTR6CA2LMNA
SCHEMBL2018411 0.72 LMNA (0.69) POLBPRMT1HTR6CA2LMNA
SCHEMBL21962677 0.72 CA12 (0.55) CA2LMNACYP19A1CA12CA1
SCHEMBL5673665 0.72 POLB (0.69) POLBPRMT1HTR6CA2LMNA
SCHEMBL22266027 0.72 KEAP1 (0.41) POLBHTR6LMNAALDH1A1HSD17B10
SCHEMBL21962605 0.71 NR1I2 (0.39) POLBLMNAPKMALDH1A1SMN1; SMN2
SCHEMBL687474 0.70 LMNA (0.61) POLBPRMT1HTR6CA2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114591293-A Fused ring compound as Nav1.8 inhibitor and application thereof 成都康弘药业集团股份有限公司 2022-06-07 — — CN disclosed
Send feedback